2014
DOI: 10.3805/eands.7.23
|View full text |Cite
|
Sign up to set email alerts
|

Rapidly Progressive Cognitive Disturbances Due to Nonconvulsive Status Epilepticus Associated with a Cerebral Microbleed: Clinical Application of FDG-PET

Abstract: Cerebral microbleeds (CMBs) usually produce no symptoms. We encountered a patient who developed cognitive decline and psychotic symptoms associated with nonconvulsive status epilepticus (NCSE), with presumptive epileptogenic focus possibly caused by a CMB. A 70-year-old man developed progressive cognitive disturbances including disorientation and hallucinations two months after a mild head injury. He was admitted to our hospital three months after the trauma, because of progression of symptoms. Vol.7 No.1 (20… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 15 publications
(26 reference statements)
0
2
0
Order By: Relevance
“…Deposition of hemosiderin, gliosis, meningocerebral cicatrix, and down-regulation of GABAergic pathway in the ischemic lesion are associated with pathogenesis of epilepsy [13][14][15]. A previous case report suggests that cerebral microbleeds may cause epileptogenic focus [16]. Therefore, the data of our patient suggest a possible association between cerebral ischemic lesions due to protein S deficiency and development of focal epileptogenicity.…”
Section: Discussionmentioning
confidence: 68%
“…Deposition of hemosiderin, gliosis, meningocerebral cicatrix, and down-regulation of GABAergic pathway in the ischemic lesion are associated with pathogenesis of epilepsy [13][14][15]. A previous case report suggests that cerebral microbleeds may cause epileptogenic focus [16]. Therefore, the data of our patient suggest a possible association between cerebral ischemic lesions due to protein S deficiency and development of focal epileptogenicity.…”
Section: Discussionmentioning
confidence: 68%
“…Additionally, the exact time of admission, and CT and MRI acquisition were also recorded. Exclusion criteria included any diagnoses of comorbidities capable of causing WM TMBs [e.g., fat embolism, chronic hypertension, cerebral amyloid angiopathy, cavernous malformations, epilepsy, Alzheimer’s disease, dementia or migraine, brain tumor, or cerebral metastasis ( Susman et al, 2002 ; Nakata-Kudo et al, 2006 ; Brain Trauma Foundation et al, 2007 ; Haacke et al, 2007 ; Oh et al, 2008 ; Ayaz et al, 2010 ; Beauchamp et al, 2013 ; Kim and Lee, 2013 ; Nakagami et al, 2014 ; Shams et al, 2015 ; Yamauchi et al, 2016 ; Trifan et al, 2017 )] based on patient medical records. Grubbs’ test was applied to exclude patients with outlier TMB numbers.…”
Section: Methodsmentioning
confidence: 99%